GLP3-RT 20mg Research Peptide
A single-molecule triple agonist targeting GLP-1, GIP, and glucagon receptors, at the frontier of metabolic research.
View Certificate of AnalysisFor Research Use Only (RUO) · Not for human or veterinary use · Delivery in 4–5 business days
A triple-receptor agonist for metabolic research.
Retatrutide represents a new generation of metabolic research compounds: a single engineered peptide designed to act as an agonist at three distinct receptors simultaneously — GLP-1, GIP, and glucagon. This multi-receptor strategy evolved from earlier dual-agonist research.
The molecule's triple activity has made it a focal point of investigation into energy metabolism and body-composition models, as researchers work to characterize how simultaneous engagement of these incretin and glucagon pathways influences metabolic signaling.
CellTheory supplies Retatrutide as a lyophilized research peptide, verified for purity by HPLC and identity by mass spectrometry, with a batch-specific Certificate of Analysis provided for each lot.
Research Applications
Incretin Pathways
Studied for combined GLP-1 and GIP receptor engagement.
Glucagon Signaling
Investigated for its glucagon-receptor agonism in metabolic models.
Energy Metabolism
A tool compound in body-composition and metabolic research.
Independently Tested.
Verified by Batch.
Batch CT24-RET-002
Questions.
GLP3-RT is supplied as a lyophilized (freeze-dried) research compound in a sealed glass vial containing 20mg. It is intended strictly for in-vitro laboratory research and is not for human or veterinary use.